Cargando…

Advances in Antibody-Based HIV-1 Vaccines Development

Detalles Bibliográficos
Autor principal:	Dietrich, Ursula
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157572/ https://www.ncbi.nlm.nih.gov/pubmed/31991723 http://dx.doi.org/10.3390/vaccines8010044

Ejemplares similares

The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses
por: Ringel, Oliver, et al.
Publicado: (2018)

Advances in Vaccine Development
por: Tripp, Ralph A.
Publicado: (2021)

Advances in HIV-1 Vaccine Development
por: Gao, Yong, et al.
Publicado: (2018)

A Strategy for Developing an HIV Vaccine
Publicado: (2005)

Systems Vaccinology in HIV Vaccine Development
por: Zhang, Jielin, et al.
Publicado: (2022)

Genomic Medicine and Advances in Vaccine Technology and Development in the Developing and Developed World
por: Cianci, Rossella, et al.
Publicado: (2020)

HIV and SARS-CoV-2 Pathogenesis and Vaccine Development
por: Fleury, Herve
Publicado: (2022)

HIV vaccine development and broadly neutralizing antibodies
por: Greenspan, Neil S., et al.
Publicado: (2015)

Recent Advances in Antibody Therapeutics
por: Heo, Yong-Seok
Publicado: (2022)

Special Issue “Recent Advances in Morbillivirus Vaccine Development and Oncolytic Virotherapy”
por: Lin, Liang-Tzung
Publicado: (2020)

New templates for HIV-1 antibody-based vaccine design
por: Sattentau, Quentin J, et al.
Publicado: (2010)

Mandatory vaccination: suited to enhance vaccination coverage in Europe?
por: Holzmann, Heidemarie, et al.
Publicado: (2019)

HIV vaccine research in Canada
por: Shattock, Robin
Publicado: (2017)

Science-based COVID-19 vaccine development
por: Gao, George F
Publicado: (2021)

Antibody‐virus co‐evolution in HIV infection: paths for HIV vaccine development
por: Bonsignori, Mattia, et al.
Publicado: (2017)

Botulinum Neurotoxins (BoNTs)—Antibody and Vaccine
por: Lou, Jianlong, et al.
Publicado: (2018)

COVID-19 Vaccines in the Pipeline, Are Antibodies Adequate?
por: Hossain, Md Kamal, et al.
Publicado: (2021)

Functional Characterization of Two scFv-Fc Antibodies from an HIV Controller Selected on Soluble HIV-1 Env Complexes: A Neutralizing V3- and a Trimer-Specific gp41 Antibody
por: Trott, Maria, et al.
Publicado: (2014)

Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
por: Ahmed, Yousuf, et al.
Publicado: (2017)

Antibody-Based HIV-1 Vaccines: Recent Developments and Future Directions: A summary report from a Global HIV Vaccine Enterprise Working Group
por: Montefiori, David, et al.
Publicado: (2007)

Recent Advances in Vaccine Technology and Design
por: Cianci, Rossella, et al.
Publicado: (2022)

Advances in vaccines: revolutionizing disease prevention
por: Tripathi, Timir
Publicado: (2023)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

Challenges in the development of T-cell–based universal influenza vaccines
por: Kang, Jung-Ok, et al.
Publicado: (2017)

Peptide-Based Vaccination for Antibody Responses Against HIV
por: Combadière, Behazine, et al.
Publicado: (2019)

Controversies and Recent Advances in Senescence and Aging
por: Wagner, Nicole, et al.
Publicado: (2023)

The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development
por: Zhang, Yu, et al.
Publicado: (2013)

Prioritise people with HIV for COVID-19 vaccination
por: HIV, The Lancet
Publicado: (2021)

Molecular Recognition and Advances in Antibody Design and Antigenic Peptide Targeting
por: Houen, Gunnar, et al.
Publicado: (2020)

Advances in Antibody Design and Antigenic Peptide Targeting 2.0
por: Trier, Nicole Hartwig, et al.
Publicado: (2023)

Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
por: Brinkkemper, Mitch, et al.
Publicado: (2019)

Substance use and the HIV care continuum: important advances
por: Korthuis, P. Todd, et al.
Publicado: (2018)

Advances in nanomedicine drug delivery applications for HIV therapy
por: Curley, Paul, et al.
Publicado: (2017)

Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)

RNA Vaccination Therapy: Advances in an Emerging Field
por: Kreiter, Sebastian, et al.
Publicado: (2016)

Advances in the control of vaccine preventable diseases in Ethiopia
por: Wondwossen, Liya, et al.
Publicado: (2017)

Technologies to advance COVID-19 vaccine equity
Publicado: (2021)

Transcutaneous Spinal Cord Stimulation: Advances in an Emerging Non-Invasive Strategy for Neuromodulation
por: Hofstoetter, Ursula S., et al.
Publicado: (2022)

Immunotherapy and Vaccine Development
por: Leung, Carol, et al.
Publicado: (2018)

HIV vaccines: progress and promise
por: Johnston, Margaret I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f1l56nr6726uj1k0ntisme90pg